Related Experiment Video
Updated: May 31, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Strategies for engineering biomimetic lipoproteins to improve drug delivery efficiency and tumor therapy
Yuchen He1,2, Naibo Yin1,2, Zhiwen Zhang3
1School of Pharmacy, Faculty of Medical and Health Sciences, the University of Auckland, Auckland, 1023, New Zealand.
Abstract:
Cancer treatment remains limited by key challenges, including poor drug biodistribution, restricted tumor penetration, and severe systemic toxicity. Lipoprotein nanoparticles (LPNs) have emerged as promising platforms for drug delivery, addressing these obstacles. Their inherent biocompatibility, small size, and natural ability to interact with specific cellular receptors make them ideal candidates for targeted cancer therapy. This review presents recent advances in the design of LPNs to improve the precision and efficiency of anti-tumor drug delivery. We investigate how these smart nanoparticles enhance the therapeutic performance of three primary treatment modalities: chemotherapy, immunotherapy, and emerging nucleic acid-based therapies. This comprehensive review summarizes current strategies in the field and offers forward-looking insights into future innovations in LPN drug delivery systems (DDSs) for cancer therapy.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

